These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A synthesis of the world's guidelines on photodynamic therapy for non-melanoma skin cancer. Morton CA G Ital Dermatol Venereol; 2018 Dec; 153(6):783-792. PubMed ID: 29417799 [TBL] [Abstract][Full Text] [Related]
5. European guidelines for topical PDT part 1 JEADV 2013; 27: 536-544. Skaria AM J Eur Acad Dermatol Venereol; 2014 May; 28(5):673. PubMed ID: 23981061 [No Abstract] [Full Text] [Related]
6. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology]. Basset-Seguin N Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714 [TBL] [Abstract][Full Text] [Related]
7. Response to Letter to the editor: 'European guidelines for topical PDT part 1. JEADV 2013;27:536-544' DOI: 10.1111/jdv.12258. Morton CA; Szeimies RM; Sidoroff A; Braathen LR J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1451-2. PubMed ID: 24666245 [No Abstract] [Full Text] [Related]
8. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215 [TBL] [Abstract][Full Text] [Related]
11. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up. Farhi D; Bedane C; Savary J; Basset-Seguin N Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280 [TBL] [Abstract][Full Text] [Related]
12. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684 [TBL] [Abstract][Full Text] [Related]
13. Daylight Photodynamic Therapy for Actinic Keratoses. Morton CA; Braathen LR Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702 [TBL] [Abstract][Full Text] [Related]
14. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? Morton CA J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514 [TBL] [Abstract][Full Text] [Related]
15. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation. Downs AM; Bower CB; Oliver DA; Stone CA Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229 [No Abstract] [Full Text] [Related]
16. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. Ortiz-Policarpio B; Lui H Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473 [TBL] [Abstract][Full Text] [Related]
17. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. Braathen LR; Szeimies RM; Basset-Seguin N; Bissonnette R; Foley P; Pariser D; Roelandts R; Wennberg AM; Morton CA; J Am Acad Dermatol; 2007 Jan; 56(1):125-43. PubMed ID: 17190630 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy: current evidence and applications in dermatology. Lee Y; Baron ED Semin Cutan Med Surg; 2011 Dec; 30(4):199-209. PubMed ID: 22123417 [TBL] [Abstract][Full Text] [Related]
19. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Varma S; Wilson H; Kurwa HA; Gambles B; Charman C; Pearse AD; Taylor D; Anstey AV Br J Dermatol; 2001 Mar; 144(3):567-74. PubMed ID: 11260016 [TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with BF-200 ALA gel for the treatment of actinic keratosis, Bowen´s disease and basal cell carcinoma in long term immunosuppressed patients after organ transplantation. González-Guerra E; Taboada AC; Muñoz LC; Fructuoso AIS Photodiagnosis Photodyn Ther; 2024 Feb; 45():103882. PubMed ID: 37949387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]